SCHEMBL821396

SCHEMBL821396

[CH2]N=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL768643 0.60
SCHEMBL639659 0.60
SCHEMBL4852319 0.55
SCHEMBL12384340 0.55
SCHEMBL3672524 0.55
SCHEMBL247948 0.55
SCHEMBL2079444 0.55
SCHEMBL38742 0.55
SCHEMBL26628 0.55
SCHEMBL443741 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820840-A1 AN IMPROVED PROCESS FOR DIASTER-EOSELECTIVE SYNTHESIS OF VICINAL DIAMINES Piramal Pharma Limited (IN) 2021-05-19 EP claimed
WO-2020012403-A1 AN IMPROVED PROCESS FOR DIASTER-EOSELECTIVE SYNTHESIS OF VICINAL DIAMINES Piramal Enterprises Limited (IN) 2020-01-16 WO claimed
EP-3820840-A1 AN IMPROVED PROCESS FOR DIASTER-EOSELECTIVE SYNTHESIS OF VICINAL DIAMINES Piramal Pharma Limited (IN) 2021-05-19 EP disclosed
EP-3820840-A1 AN IMPROVED PROCESS FOR DIASTER-EOSELECTIVE SYNTHESIS OF VICINAL DIAMINES Piramal Pharma Limited (IN) 2021-05-19 EP disclosed
US-10888853-B2 Cinchonium betaine catalysts and methods of using same BRANDEIS UNIVERSITY (US) 2021-01-12 US disclosed
US-10836761-B2 Cinchonine-derived catalysts and methods of using same BRANDEIS UNIVERSITY (US) 2020-11-17 US disclosed
US-20200147593-A1 Cinchonium betaine catalysts and methods of using same BRANDEIS UNIVERSITY 2020-05-14 US disclosed
US-10610857-B2 Cinchonium betaine catalysts and methods of using same BRANDEIS UNIVERSITY (US) 2020-04-07 US disclosed
US-20200048243-A1 CINCHONINE-DERIVED CATALYSTS AND METHODS OF USING SAME BRANDEIS UNIVERSITY (US) 2020-02-13 US disclosed
WO-2020012403-A1 AN IMPROVED PROCESS FOR DIASTER-EOSELECTIVE SYNTHESIS OF VICINAL DIAMINES Piramal Enterprises Limited (IN) 2020-01-16 WO disclosed
WO-2020012403-A1 AN IMPROVED PROCESS FOR DIASTER-EOSELECTIVE SYNTHESIS OF VICINAL DIAMINES Piramal Enterprises Limited (IN) 2020-01-16 WO disclosed
US-20070244328-A1 Organocatalysts and Methods of Use in Chemical Synthesis STC.UNM (US) 2007-10-18 US disclosed
WO-2006007586-A1 ORGANOCATALYSTS AND METHODS OF USE IN CHEMICAL SYNTHESIS SCIENCE & TECHNOLOGY CORPORATION @ UNM (US) 2006-01-19 WO disclosed
US-6617456-B1 Aminoalkoxy- or hydroxyalkoxy- camptothecin compound that can be bound to a polysaccharide having carboxyl groups via an amino acid or a peptide group; antitumor agents TANABE SEIYAKU CO., LTD. (JP) 2003-09-09 US disclosed
US-6512118-B1 Pharmaceutically acceptable salt thereof show excellent antitumor activities against various tumors, especially they show excellent therapeutic effects on solid tumors such as pulmonary cancer, uterine cancer, ovarian cancer, breast TANABE SEIYAKU CO., LTD. (JP) 2003-01-28 US disclosed
EP-0781781-B1 Camptothecin derivatives TANABE SEIYAKU CO (JP) 2001-10-10 EP disclosed
US-5892043-A MIXTURE WITH POLYSACCHARIDE AND PEPTIDE; ANTITUMOR AGENT TANABE SEIYAKU CO., LTD. (JP) 1999-04-06 US disclosed
EP-0781781-A2 Camptothecin derivatives TANABE SEIYAKU CO., LTD. (JP) 1997-07-02 EP disclosed
US-5594008-A ANTIINFLAMMATORY AGENTS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1997-01-14 US disclosed
EP-0657451-A2 Pyrrolidine derivatives inhibitors of leukotriene biosynthesis BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1995-06-14 EP disclosed